Search Results - "Salloum, Naji"

Staging Treatment Intensity and Defining Resistant Depression: Historical Overview and Future Directions by Salloum, Naji C, Papakostas, George I

“…To review existing staging models and definitions of treatment-resistant depression (TRD) and offer future directions within the context of up-to-date…”
Get full text

A reciprocal effects analysis of cannabis use and perceptions of risk by Salloum, Naji C., Krauss, Melissa J., Agrawal, Arpana, Bierut, Laura J., Grucza, Richard A.

“…Background and Aims Adolescents and young adults increasingly view cannabis as a relatively safe drug. Perception of risk associated with cannabis use is…”
Get full text

Success and efficiency of phase 2/3 adjunctive trials for MDD funded by industry: a systematic review by Salloum, Naji C., Fava, Maurizio, Ball, Sophia, Papakostas, George I.

“…To review the success rate and efficiency of industry-sponsored phase 2/3 clinical trials for adjunctive therapies for antidepressant partial- and…”
Get full text

Efficacy of Esketamine Augmentation in Major Depressive Disorder: A Meta-Analysis by Papakostas, George I, Salloum, Naji C, Hock, Rebecca S, Jha, Manish K, Murrough, James W, Mathew, Sanjay J, Iosifescu, Dan V, Fava, Maurizio

“…Esketamine, the S-enantiomer of ketamine, was recently approved as a rapid-acting intranasal therapy for depression and is currently under development for…”
Get full text

Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment‐resistant depression by Salloum, Naji C., Fava, Maurizio, Freeman, Marlene P., Flynn, Martina, Hoeppner, Bettina, Hock, Rebecca S., Cusin, Cristina, Iosifescu, Dan V., Trivedi, Madhukar H., Sanacora, Gerard, Mathew, Sanjay J., Debattista, Charles, Ionescu, Dawn F., Papakostas, George I.

“…Objective To examine the effect of high baseline anxiety on response to ketamine versus midazolam (active placebo) in treatment‐resistant depression (TRD)…”
Get full text

Time to relapse after a single administration of intravenous ketamine augmentation in unipolar treatment-resistant depression by Salloum, Naji C., Fava, Maurizio, Hock, Rebecca S., Freeman, Marlene P., Flynn, Martina, Hoeppner, Bettina, Cusin, Cristina, Iosifescu, Dan V., Trivedi, Madhukar H., Sanacora, Gerard, Mathew, Sanjay J., Debattista, Charles, Ionescu, Dawn F., Papakostas, George I.

“…•A quarter of patients in remission post-ketamine infusion relapsed 7 days post-treatment.•Time to relapse after successful ketamine treatment follows a…”
Get full text

Emergence of mania in two middle‐aged patients with a history of unipolar treatment‐refractory depression receiving vagus nerve stimulation by Salloum, Naji C, Walker, Marie C, Gangwani, Sunil, Conway, Charles R

“…Objectives We report on two patients who experienced emergence of full manic symptoms while receiving vagal nerve stimulation (VNS). Methods Two patients, both…”
Get full text

Towards the clinical implementation of pharmacogenetics in bipolar disorder by Salloum, Naji C, McCarthy, Michael J, Leckband, Susan G, Kelsoe, John R

“…Bipolar disorder (BD) is a psychiatric illness defined by pathological alterations between the mood states of mania and depression, causing disability,…”
Get full text

Sustained remission in patients with treatment-resistant depression receiving Vagal Nerve Stimulation: A case series by Salloum, Naji C, Gott, Britt M, Conway, Charles R

“…Highlights • VNS in treatment-resistant depression can help sustain near-permanent remission. • VNS was very well tolerated by all patients without any major…”
Get full text

From genes to treatments: a systematic review of the pharmacogenetics in smoking cessation by Salloum, Naji C, Buchalter, Erica LF, Chanani, Swati, Espejo, Gemma, Ismail, Mahjabeen S, Laine, Randy O, Nageeb, Maysaa, Srivastava, A Benjamin, Trapp, Nicholas, Trillo, Ludwig, Vance, Erica, Wenzinger, Michael, Hartz, Sarah M, David, Sean P, Chen, Li-Shiun

“…Smoking cessation treatment outcomes may be heavily influenced by genetic variations among smokers. Therefore, identifying specific variants that affect…”
Get full text

Safety and Clinical Efficacy Outcomes From the Long-term Extension Study of Tolebrutinib in Participants With Relapsing Multiple Sclerosis: 2.5-Year Results (S16.010) by Oh, Jiwon, Syed, Sana, Li, Tong, Salloum, Naji, Turner, Timothy J., Fox, Robert J.

“…Abstract only…”
Get full text

Emergence of mania in two middle-aged patients with a history of unipolar treatment-refractory depression receiving vagus nerve stimulation by Salloum, Naji C, Walker, Marie C, Gangwani, Sunil, Conway, Charles R

“…OBJECTIVESWe report on two patients who experienced emergence of full manic symptoms while receiving vagal nerve stimulation (VNS).METHODSTwo patients, both…”
Get full text